Bain Capital Life Sciences Investors, LLC Portfolio Holdings

Bain Capital Life Sciences Investors, LLC

  • $312 Million
  • Q3 2025

Bain Capital Life Sciences Investors, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $312 Million distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $79.4M, Olema Pharmaceuticals, Inc. with a value of $66M, Savara Inc with a value of $62M, Rapid Micro Biosystems, Inc. with a value of $27.9M, and Tango Therapeutics, Inc. with a value of $22.8M.

Examining the 13F form we can see an decrease of $21.8M in the current position value, from $333M to 312M.

Bain Capital Life Sciences Investors, LLC is based out at Boston, MA

Below you can find more details about Bain Capital Life Sciences Investors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $312 Million
Healthcare: $312 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$795M
$79.4 Million 25.47% of portfolio
3,181,275
Q3 2025 Reduced 3.7%
$351M
$66 Million 21.2% of portfolio
6,843,954
Q1 2025 Reduced 8.38%
$495M
$62 Million 19.88% of portfolio
17,600,621
Q1 2025 Added 20.84%
$152M
$27.9 Million 8.96% of portfolio
8,434,560
Q3 2021 New
$720M
$22.8 Million 7.31% of portfolio
2,712,008
Q3 2024 Reduced 6.25%
$67M
$22.5 Million 7.24% of portfolio
9,677,125
Q2 2025 Added 250.51%
$136M
$15.6 Million 5.02% of portfolio
5,249,069
Q4 2024 Reduced 37.88%
$246M
$7.21 Million 2.31% of portfolio
2,485,638
Q4 2021 Reduced 32.82%
$19.2M
$3.88 Million 1.25% of portfolio
4,566,817
Q3 2024 Added 20.64%
$121M
$2.47 Million 0.79% of portfolio
1,111,910
Q2 2024 Reduced 2.65%
$27.7M
$1.77 Million 0.57% of portfolio
3,538,609
Q3 2025 Reduced 34.6%
X4 Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 332.13%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 6.28%
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 96.1%
Mersana Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 20.81%
Heartflow Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
-
$0 0.0% of portfolio
-
Q4 2022 New
Kyverna Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 6.46%
-
$0 0.0% of portfolio
-
Q4 2024 Added 2.34%

Summary

  • Portfolio
  • No. of Stocks 21
  • Current Value $312 Million
  • Prior Value $333 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 2 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email